Skip to Main Content (Press Enter)

Logo UNIMI
  • ×
  • Home
  • People
  • Projects
  • Fields
  • Units
  • Outputs
  • Third Mission

Expertise & Skills
Logo UNIMI

|

Expertise & Skills

unimi.it
  • ×
  • Home
  • People
  • Projects
  • Fields
  • Units
  • Outputs
  • Third Mission
  1. Outputs

RNA molecular signature profiling in PBMCs of sporadic ALS patients: HSP70 overexpression is associated with nuclear SOD1

Academic Article
Publication Date:
2022
Citation:
RNA molecular signature profiling in PBMCs of sporadic ALS patients: HSP70 overexpression is associated with nuclear SOD1 / M. Garofalo, C. Pandini, M. Bordoni, E. Jacchetti, L. Diamanti, S. Carelli, M.T. Raimondi, D. Sproviero, V. Crippa, S. Carra, A. Poletti, O. Pansarasa, S. Gagliardi, C. Cereda. - In: CELLS. - ISSN 2073-4409. - 11:2(2022 Jan 15), pp. 293.1-293.18. [10.3390/cells11020293]
abstract:
Superoxide dismutase 1 (SOD1) is one of the causative genes associated with amyotrophic lateral sclerosis (ALS), a neurodegenerative disorder. SOD1 aggregation contributes to ALS patho-genesis. A fraction of the protein is localized in the nucleus (nSOD1), where it seems to be involved in the regulation of genes participating in the oxidative stress response and DNA repair. Peripheral blood mononuclear cells (PBMCs) were collected from sporadic ALS (sALS) patients (n = 18) and healthy controls (n = 12) to perform RNA-sequencing experiments and differential expression analysis. Patients were stratified into groups with “high” and “low” levels of nSOD1. We obtained different gene expression patterns for high-and low-nSOD1 patients. Differentially expressed genes in high nSOD1 form a cluster similar to controls compared to the low-nSOD1 group. The pathways activated in high-nSOD1 patients are related to the upregulation of HSP70 molecular chaperones. We demonstrated that, in this condition, the DNA damage is reduced, even under oxidative stress conditions. Our findings highlight the importance of the nuclear localization of SOD1 as a protective mechanism in sALS patients.
IRIS type:
01 - Articolo su periodico
Keywords:
ALS; DNA damage; HSP70; SOD1; transcriptomics
List of contributors:
M. Garofalo, C. Pandini, M. Bordoni, E. Jacchetti, L. Diamanti, S. Carelli, M.T. Raimondi, D. Sproviero, V. Crippa, S. Carra, A. Poletti, O. Pansarasa, S. Gagliardi, C. Cereda
Authors of the University:
CEREDA CRISTINA ( author )
CRIPPA VALERIA ( author )
POLETTI ANGELO ( author )
Link to information sheet:
https://air.unimi.it/handle/2434/900724
Full Text:
https://air.unimi.it/retrieve/handle/2434/900724/1962624/cells-11-00293.pdf
Project:
Colchicine for Amyotrophic Lateral Sclerosis: a phase II, randomized, double blind, placebo controlled, multicenter clinical trial (Co-ALS)
  • Research Areas

Research Areas

Concepts


Settore BIO/13 - Biologia Applicata
  • Guide
  • Help
  • Accessibility
  • Privacy
  • Use of cookies
  • Legal notices

Powered by VIVO | Designed by Cineca | 26.4.3.0